The involvement of IL-9 in AD is still unexplored, even though a recent study on an experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis highlighted IL-9 as a critical neuroprotective molecule, capable of interfering with inflammatory synaptopathy (Guadalupi et al., 2024). Here, IL9 is linked to experimental autoimmune encephalomyelitis.